Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Nanette Wenger

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Concepts & Ideas

Disorders

Chemicals & Drugs

Living Beings

African Continental Ancestry Group

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Parashar Susmita; Katz Ronit; Smith Nicholas L; Arnold Alice M; Vaccarino Viola; Wenger Nanette K; Gottdiener John S
Race, gender, and mortality in adults > or =65 years of age with incident heart failure (from the Cardiovascular Health Study).
Collins Peter; Mosca Lori; Geiger Mary Jane; Grady Deborah; Kornitzer Marcel; Amewou-Atisso Messan G; Effron Mark B; Dowsett Sherie A; Barrett-Connor Elizabeth; Wenger Nanette K
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors.
McCall-Hosenfeld Jennifer S; Jaramillo Sarah A; Legault Claudine; Freund Karen M; Cochrane Barbara B; Manson Joann E; Wenger Nanette K; Eaton Charles B; Rodriguez Beatriz L; McNeeley S Gene; Bonds Denise;
Correlates of sexual satisfaction among sexually active postmenopausal women in the Women's Health Initiative-Observational Study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Nanette Wenger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Parashar Susmita; Katz Ronit; Smith Nicholas L; Arnold Alice M; Vaccarino Viola; Wenger Nanette K; Gottdiener John S
Race, gender, and mortality in adults > or =65 years of age with incident heart failure (from the Cardiovascular Health Study).
The American journal of cardiology 2009;103(8):1120-7.
2009: Collins Peter; Mosca Lori; Geiger Mary Jane; Grady Deborah; Kornitzer Marcel; Amewou-Atisso Messan G; Effron Mark B; Dowsett Sherie A; Barrett-Connor Elizabeth; Wenger Nanette K
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors.
Circulation 2009;119(7):922-30.
2008: McCall-Hosenfeld Jennifer S; Jaramillo Sarah A; Legault Claudine; Freund Karen M; Cochrane Barbara B; Manson Joann E; Wenger Nanette K; Eaton Charles B; Rodriguez Beatriz L; McNeeley S Gene; Bonds Denise;
Correlates of sexual satisfaction among sexually active postmenopausal women in the Women's Health Initiative-Observational Study.
Journal of general internal medicine 2008;23(12):2000-9.
2008: Engberding Niels; Wenger Nanette K
Cardiovascular disease prevention tailored for women.
Expert review of cardiovascular therapy 2008;6(8):1123-34.
2008: Shepherd James; Kastelein John P; Bittner Vera A; Carmena Rafael; Deedwania Prakash C; Breazna Andrei; Dobson Stephen; Wilson Daniel J; Zuckerman Andrea L; Wenger Nannette K;
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease.
Mayo Clinic proceedings. Mayo Clinic 2008;83(8):870-9.
2008: Tinker Lesley F; Bonds Denise E; Margolis Karen L; Manson JoAnn E; Howard Barbara V; Larson Joseph; Perri Michael G; Beresford Shirley A A; Robinson Jennifer G; Rodríguez Beatriz; Safford Monika M; Wenger Nanette K; Stevens Victor J; Parker Linda M;
Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial.
Archives of internal medicine 2008;168(14):1500-11.
2008: Grady Deborah; Cauley Jane A; Geiger Mary Jane; Kornitzer Marcel; Mosca Lori; Collins Peter; Wenger Nanette K; Song Jingli; Mershon John; Barrett-Connor Elizabeth;
Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk.
Journal of the National Cancer Institute 2008;100(12):854-61.
2008: Shah Sanjiv J; Waters David D; Barter Philip; Kastelein John J P; Shepherd James; Wenger Nanette K; DeMicco David A; Breazna Andrei; LaRosa John C
Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery.
Journal of the American College of Cardiology 2008;51(20):1938-43.
2008: Wenger Nanette K
Current status of cardiac rehabilitation.
Journal of the American College of Cardiology 2008;51(17):1619-31.
2008: Shepherd James; Kastelein John J P; Bittner Vera; Deedwania Prakash; Breazna Andrei; Dobson Stephen; Wilson Daniel J; Zuckerman Andrea; Wenger Nanette K;
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
Journal of the American College of Cardiology 2008;51(15):1448-54.
2008: McCall-Hosenfeld Jennifer S; Freund Karen M; Legault Claudine; Jaramillo Sarah A; Cochrane Barbara B; Manson Joann E; Wenger Nanette K; Eaton Charles B; McNeeley S Gene; Rodriguez Beatriz L; Bonds Denise
Sexual satisfaction and cardiovascular disease: the Women's Health Initiative.
The American journal of medicine 2008;121(4):295-301.
2008: Wenger N K; Lewis S J; Welty F K; Herrington D M; Bittner V;
Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study.
Heart (British Cardiac Society) 2008;94(4):434-9.
2008: Wenger Nanette K
Women in leadership positions in the medical academic enterprise: what are the next steps?
Archives of internal medicine 2008;168(5):449-50.
2008: Kowey Peter R; Wenger Nanette K; Weber Michael A; Lavie Carl J
The geriatric paradox.
The American journal of geriatric cardiology 2008;17(2):69-70.
2008: Wenger Nanette K
Preventing cardiovascular disease in women: an update.
Clinical cardiology 2008;31(3):109-13.
2008: Weber Michael A; Wenger Nanette K
Progress in treating hypertension.
The American journal of geriatric cardiology 2008;17(1):5-6.
2008: Wenger Nanette K
Women, their age, and their cholesterol values.
Cardiology in review 2008;16(1):21-2.
2008: Wenger Nanette K
Drugs for cardiovascular disease prevention in women: implications of the AHA Guidelines--2007 Update.
Drugs 2008;68(3):339-58.
2008: Snyder Gene P; Ferretti Elizabeth B; Wenger Nanette K; Strobeck John E; Silver Marc A; Sowers James R; Engler Marguerite M; Amsterdam Ezra A; Weinberg Sylvan Lee; Parish Lawrence Charles; Moser Marvin
Accountability and transparency in medical publishing: position and policies of le jacq on authorship, acknowledgments, conflicts of interest, and secondary and redundant publication.
The American heart hospital journal 2008;6(1):5-8.
2007: Wenger Nanette K
Do diet, folic acid, and vitamins matter? What did we learn from the Women's Health Initiative, the Women's Health Study, the Women's Antioxidant and Folic Acid Cardiovascular Study, and other clinical trials?
Cardiology in review 2007;15(6):288-90.
2007: Wenger Nanette K
Exploring sex/gender differences in women's cardiovascular health.
Cardiology in review 2007;15(6):273-4.
2007: Wenger Nanette K; Weber Michael A
Newer diagnostic strategies, application of evidence-based therapies: improving cardiovascular outcomes in an expanding elderly population.
The American journal of geriatric cardiology 2007;16(6):337-8.
2007: Shepherd James; Kastelein John J P; Bittner Vera; Deedwania Prakash; Breazna Andrei; Dobson Stephen; Wilson Daniel J; Zuckerman Andrea; Wenger Nanette K;
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(6):1131-9.
2007: Weber Michael A; Wenger Nanette K
Drug choice affects treatment compliance and blood pressure outcomes in elderly hypertensive patients.
The American journal of geriatric cardiology 2007;16(5):277-8.
2007: Anderson Jeffrey L; Adams Cynthia D; Antman Elliott M; Bridges Charles R; Califf Robert M; Casey Donald E; Chavey William E; Fesmire Francis M; Hochman Judith S; Levin Thomas N; Lincoff A Michael; Peterson Eric D; Theroux Pierre; Wenger Nanette Kass; Wright R Scott; Smith Sidney C; Jacobs Alice K; Adams Cynthia D; Anderson Jeffrey L; Antman Elliott M; Halperin Jonathan L; Hunt Sharon A; Krumholz Harlan M; Kushner Frederick G; Lytle Bruce W; Nishimura Rick; Ornato Joseph P; Page Richard L; Riegel Barbara;
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
Journal of the American College of Cardiology 2007;50(7):e1-e157.
2007: Anderson Jeffrey L; Adams Cynthia D; Antman Elliott M; Bridges Charles R; Califf Robert M; Casey Donald E; Chavey William E; Fesmire Francis M; Hochman Judith S; Levin Thomas N; Lincoff A Michael; Peterson Eric D; Theroux Pierre; Wenger Nanette Kass; Wright R Scott; Smith Sidney C; Jacobs Alice K; Halperin Jonathan L; Hunt Sharon A; Krumholz Harlan M; Kushner Frederick G; Lytle Bruce W; Nishimura Rick; Ornato Joseph P; Page Richard L; Riegel Barbara;
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
Circulation 2007;116(7):e148-304.
2007: Wenger Nanette K
Heightened cardiovascular risk in diabetic women: can the tide be turned?
Annals of internal medicine 2007;147(3):208-10.
2007: Scheidt Stephen; Wenger Nanette K; Weber Michael A
Patient selection, statistical presumption, and uncertainty of outcomes.
The American journal of geriatric cardiology 2007;16(4):213-5.
2007: Wenger Nanette K; Lewis Sandra J; Herrington David M; Bittner Vera; Welty Francine K;
Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease.
Annals of internal medicine 2007;147(1):1-9.
2007: Wenger Nanette K
The Reynolds Risk Score: improved accuracy for cardiovascular risk prediction in women?
Nature clinical practice. Cardiovascular medicine 2007;4(7):366-7.
2007: Wenger Nanette K; Scheidt Stephen; Weber Michael
Cardiovascular risk factors, cardiovascular disease, cardiovascular drug therapies, and dementia/cognitive dysfunction: how do the pieces of the puzzle fit together?
The American journal of geriatric cardiology 2007;16(3):133-5.
2007: Thompson Paul D; Franklin Barry A; Balady Gary J; Blair Steven N; Corrado Domenico; Estes N A Mark; Fulton Janet E; Gordon Neil F; Haskell William L; Link Mark S; Maron Barry J; Mittleman Murray A; Pelliccia Antonio; Wenger Nanette K; Willich Stefan N; Costa Fernando;
Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology.
Circulation 2007;115(17):2358-68.
2007: Wenger Nanette K
The greying of cardiology: implications for management.
Heart (British Cardiac Society) 2007;93(4):411-2.
2007: Weber Michael; Wenger Nanette K; Scheidt Stephen
Observational studies can help fill important gaps in understanding and treating cardiovascular disease in the elderly.
The American journal of geriatric cardiology 2007;16(2):65-6.
2007: Hsia Judith; Margolis Karen L; Eaton Charles B; Wenger Nanette K; Allison Matthew; Wu LieLing; LaCroix Andrea Z; Black Henry R;
Prehypertension and cardiovascular disease risk in the Women's Health Initiative.
Circulation 2007;115(7):855-60.
2007: Khush Kiran K; Waters David D; Bittner Vera; Deedwania Prakash C; Kastelein John J P; Lewis Sandra J; Wenger Nanette K
Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study.
Circulation 2007;115(5):576-83.
2007: Scheidt Stephen; Wenger Nanette K; Weber Michael A
Denial of standard treatment to the elderly: why?
The American journal of geriatric cardiology 2007;16(1):5-7.
2007: Wenger Nanette K; Chaitman Bernard; Vetrovec George W
Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials.
The American journal of cardiology 2007;99(1):11-8.
2006: Wenger Nanette K
Enrollment and maintenance of elderly patients in cardiovascular clinical trials.
The American journal of geriatric cardiology 2006;15(6):352-6.
2006: Weber Michael A; Wenger Nanette K; Scheidt Stephen
Who should be treated with implantable cardioverter-defibrillators?
The American journal of geriatric cardiology 2006;15(6):336-7.
2006: Wenger Nanette K
Lipid abnormalities in women: data for risk, data for management.
Cardiology in review 2006;14(6):276-80.
2006: Wenger Nanette K
[Menopausal hormone therapy and cardiovascular disease]
Revista española de cardiología 2006;59(10):1058-69.
2006: Parashar Susmita; Rumsfeld John S; Spertus John A; Reid Kimberly J; Wenger Nanette K; Krumholz Harlan M; Amin Alpesh; Weintraub William S; Lichtman Judith; Dawood Nazeera; Vaccarino Viola
Time course of depression and outcome of myocardial infarction.
Archives of internal medicine 2006;166(18):2035-43.
2006: Wenger Nanette K; Weber Michael A; Scheidt Stephen
Valvular heart disease at elderly age: new vistas.
The American journal of geriatric cardiology 2006;15(5):273-4.
2006: Gomberg-Maitland Mardi; Wenger Nanette K; Feyzi Jan; Lengyel Maria; Volgman Annabelle S; Petersen Palle; Frison Lars; Halperin Jonathan L
Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials.
European heart journal 2006;27(16):1947-53.
2006: Barrett-Connor Elizabeth; Mosca Lori; Collins Peter; Geiger Mary Jane; Grady Deborah; Kornitzer Marcel; McNabb Michelle A; Wenger Nanette K;
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.
The New England journal of medicine 2006;355(2):125-37.
2006: Argulian Edgar; Patel Amar D; Abramson Jerome L; Kulkarni Aniket; Champney Kimberly; Palmer Spencer; Weintraub William; Wenger Nanette K; Vaccarino Viola
Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions.
The American journal of cardiology 2006;98(1):48-53.
2006: Wenger Nanette K; Weber Michael A; Scheidt Stephen
Coronary risk attributes, coronary risk reduction, and clinical outcomes.
The American journal of geriatric cardiology 2006;15(3):140-1.
2006: Mallik Susmita; Spertus John A; Reid Kimberly J; Krumholz Harlan M; Rumsfeld John S; Weintraub William S; Agarwal Purva; Santra Mugdha; Bidyasar Savita; Lichtman Judith H; Wenger Nanette K; Vaccarino Viola;
Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women.
Archives of internal medicine 2006;166(8):876-83.
2006: Wenger Nanette K
Coronary heart disease in women: highlights of the past 2 years--stepping stones, milestones and obstructing boulders.
Nature clinical practice. Cardiovascular medicine 2006;3(4):194-202.
2006: Hall W Dallas; Watkins Laurence O; Wright Jackson T; Wenger Nanette K; Kumanyika Shiriki K; Gavin James R; Ferdinand Keith C; Watson Karol; Clark Luther T; Flack John M; Reed James W; Horton Ella W; Saunders Elijah;
The metabolic syndrome: recognition and management.
Disease management : DM 2006;9(1):16-33.
2006: Pohlel Khan; Grow Parker; Helmy Tarek; Wenger Nanette K
Treating dyslipidemia in the elderly.
Current opinion in lipidology 2006;17(1):54-7.
2005: Wenger Nanette K; Geiger Mary Jane
Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene.
Contemporary clinical trials 2005;26(6):612-5.
2005: King Marjorie L; Williams Mark A; Fletcher Gerald F; Gordon Neil F; Gulanick Meg; King Carl N; Leon Arthur S; Levine Benjamin D; Costa Fernando; Wenger Nanette K;
Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs. A statement for healthcare professionals from the American Association for Cardiovascular and Pulmonary Rehabilitation and the American Heart Association.
Journal of cardiopulmonary rehabilitation 2005;25(6):315-20.
2005: King Marjorie L; Williams Mark A; Fletcher Gerald F; Gordon Neil F; Gulanick Meg; King Carl N; Leon Arthur S; Levine Benjamin D; Costa Fernando; Wenger Nanette K;
Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: a scientific statement from the American Heart Association/American Association for Cardiovascular and Pulmonary Rehabilitation.
Circulation 2005;112(21):3354-60.
2005: Wenger Nanette K; Weber Michael A; Scheidt Stephen
Medicare drug therapy in the elderly: pharmacotherapy, politics, and economics at the crossroads.
The American journal of geriatric cardiology 2005;14(6):282-3.
2005: Weber Michael A; Wenger Nanette K; Scheidt Stephen
A focus on heart failure and other age-related cardiovascular conditions.
The American journal of geriatric cardiology 2005;14(5):221-3.
2005: Vaccarino Viola; Rathore Saif S; Wenger Nanette K; Frederick Paul D; Abramson Jerome L; Barron Hal V; Manhapra Ajay; Mallik Susmita; Krumholz Harlan M;
Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002.
The New England journal of medicine 2005;353(7):671-82.
2005: Wenger Nanette K
Coronary revascularization in women.
Cardiology in review 2005;13(4):184-9.
2005: Hanna Ibrahim R; Wenger Nanette K
Secondary prevention of coronary heart disease in elderly patients.
American family physician 2005;71(12):2289-96.
2005: Wenger Nanette K
Menopausal hormone therapy: currently no evidence for cardiac protection.
Pediatric blood & cancer 2005;44(7):625-9.
2005: LaRosa John C; Grundy Scott M; Waters David D; Shear Charles; Barter Philip; Fruchart Jean-Charles; Gotto Antonio M; Greten Heiner; Kastelein John J P; Shepherd James; Wenger Nanette K;
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
The New England journal of medicine 2005;352(14):1425-35.
2005: Mieres Jennifer H; Shaw Leslee J; Arai Andrew; Budoff Matthew J; Flamm Scott D; Hundley W Gregory; Marwick Thomas H; Mosca Lori; Patel Ayan R; Quinones Miguel A; Redberg Rita F; Taubert Kathryn A; Taylor Allen J; Thomas Gregory S; Wenger Nanette K;
Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association.
Circulation 2005;111(5):682-96.
2005: Kurella Manjula; Yaffe Kristine; Shlipak Michael G; Wenger Nanette K; Chertow Glenn M
Chronic kidney disease and cognitive impairment in menopausal women.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(1):66-76.
2005: Scheidt Stephen; Wenger Nanette K; Weber Michael
Modern cardiac electrophysiology and the elderly.
The American journal of geriatric cardiology 2005;14(1):6-8.
2005: Wenger Nanette Kass; Helmy Tarek; Patel Amar D; Hanna Ibrahim R
Approaching cardiac arrhythmias in the elderly patient.
MedGenMed : Medscape general medicine 2005;7(4):24.
2005: Helmy Tarek; Patel Amar D; Alameddine Fadi; Wenger Nanette K
Management strategies of dyslipidemia in the elderly: 2005.
MedGenMed : Medscape general medicine 2005;7(4):8.
2005: Champney Kimberly P; Wenger Nanette K
Recognition and prevention of cardiovascular disease in women.
Comprehensive therapy 2005;31(4):255-61.
2005: Wenger Nanette Kass; Helmy Tarek; Patel Amar D; Lerakis Stamatios
Evidence-based management of coronary artery disease in the elderly--current perspectives.
MedGenMed : Medscape general medicine 2005;7(2):75.
2005: Wenger Nanette Kass; Helmy Terek; Khan Bobby V; Patel Amar D
Evidence-based management of acute myocardial infarction in the elderly--current perspectives.
MedGenMed : Medscape general medicine 2005;7(1):73.
2004: Wenger Nanette K; Weber Michael A; Scheidt Stephen
Hippocrates, Maimonides, and End-of-Life Issues.
The American journal of geriatric cardiology 2004;13(6):291-2.
2004: Weber Michael A; Wenger Nanette K; Scheidt Stephen
Common cardiac conditions in the elderly are still not well understood.
The American journal of geriatric cardiology 2004;13(5):237-8.
2004: Wenger Nanette K
Diet and exercise for perimenopausal women lifestyle interventions can decrease cardiovascular risk.
Journal of the American College of Cardiology 2004;44(3):586-7.
2004: Wenger Nanette K; Gregoratos Gabriel; Kitzman Dalane W; Scheidt Stephen; Weber Michael A; Alpert Joseph S;
Guidelines of the Cardiogeriatrics Department of the Brazilian Cardiology Society: commentary by Editorial Board Members of The American Journal of Geriatric Cardiology.
The American journal of geriatric cardiology 2004;13(4):209-16.
2004: Weber Michael A; Wenger Nanette K; Scheidt Stephen
The elderly and cardiovascular disease: some differences, but many similarities to their younger counterparts.
The American journal of geriatric cardiology 2004;13(4):178-9.
2004: Wenger Nanette K
Chronic kidney disease is a cardiovascular problem--implications for lipid management.
The American journal of cardiology 2004;94(2):167-8.
2004: Wenger Nanette K
Dyslipidemia as a risk factor at elderly age.
The American journal of geriatric cardiology 2004;13(3 Suppl 1):4-9.
2004: Wenger Nanette K; Weber Michael A; Scheidt Stephen
The Cardiovascular Health Study: a national treasure of cardiovascular information about the elderly.
The American journal of geriatric cardiology 2004;13(2):57-8.
2004: Mosca Lori; Appel Lawrence J; Benjamin Emelia J; Berra Kathy; Chandra-Strobos Nisha; Fabunmi Rosalind P; Grady Deborah; Haan Constance K; Hayes Sharonne N; Judelson Debra R; Keenan Nora L; McBride Patrick; Oparil Suzanne; Ouyang Pamela; Oz Mehmet C; Mendelsohn Michael E; Pasternak Richard C; Pinn Vivian W; Robertson Rose Marie; Schenck-Gustafsson Karin; Sila Cathy A; Smith Sidney C; Sopko George; Taylor Anne L; Walsh Brian W; Wenger Nanette K; Williams Christine L;
Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(3):e29-50.
2004: Mosca Lori; Appel Lawrence J; Benjamin Emelia J; Berra Kathy; Chandra-Strobos Nisha; Fabumni Rosalind P; Grady Deborah; Haan Constance K; Hayes Sharonne N; Judelson Debra R; Keenan Nora L; McBride Patrick; Oparil Suzanne; Ouyang Pamela; Oz Mehmet C; Mendelsohn Michael E; Pasternak Richard C; Pinn Vivian W; Robertson Rose Marie; Schenck-Gustafsson Karin; Sila Cathy A; Smith Sidney C; Sopko George; Taylor Anne L; Walsh Brian W; Wenger Nanette K; Williams Christine L;
Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(3):394-6.
2004: Mosca Lori; Appel Lawrence J; Benjamin Emelia J; Berra Kathy; Chandra-Strobos Nisha; Fabunmi Rosalind P; Grady Deborah; Haan Constance K; Hayes Sharonne N; Judelson Debra R; Keenan Nora L; McBride Patrick; Oparil Suzanne; Ouyang Pamela; Oz Mehmet C; Mendelsohn Michael E; Pasternak Richard C; Pinn Vivian W; Robertson Rose Marie; Schenck-Gustafsson Karin; Sila Cathy A; Smith Sidney C; Sopko George; Taylor Anne L; Walsh Brian W; Wenger Nanette K; Williams Christine L;
Evidence-based guidelines for cardiovascular disease prevention in women.
Journal of the American College of Cardiology 2004;43(5):900-21.
2004: Husak Liudmila; Vaccarino Viola; Veledar Emir; Murrah Nancy; Wenger Nanette K
Comparison of angiographic findings among postmenopausal women using unopposed estrogen, estrogen/progestin combinations, and nonusers.
The American journal of cardiology 2004;93(5):563-8.
2004: Wenger Nanette K
You've come a long way, baby: cardiovascular health and disease in women: problems and prospects.
Circulation 2004;109(5):558-60.
2004: Mosca Lori; Appel Lawrence J; Benjamin Emelia J; Berra Kathy; Chandra-Strobos Nisha; Fabunmi Rosalind P; Grady Deborah; Haan Constance K; Hayes Sharonne N; Judelson Debra R; Keenan Nora L; McBride Patrick; Oparil Suzanne; Ouyang Pamela; Oz Mehmet C; Mendelsohn Michael E; Pasternak Richard C; Pinn Vivian W; Robertson Rose Marie; Schenck-Gustafsson Karin; Sila Cathy A; Smith Sidney C; Sopko George; Taylor Anne L; Walsh Brian W; Wenger Nanette K; Williams Christine L;
Evidence-based guidelines for cardiovascular disease prevention in women.
Circulation 2004;109(5):672-93.
2004: Waters David D; Guyton John R; Herrington David M; McGowan Mary P; Wenger Nanette K; Shear Charles;
Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?
The American journal of cardiology 2004;93(2):154-8.
2004: Shlipak Michael G; Stehman-Breen Catherine; Vittinghoff Eric; Lin Feng; Varosy Paul D; Wenger Nanette K; Furberg Curt D;
Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(1):37-44.
2004: Wenger Nanette K
Menopausal hormone therapy: is there evidence for cardiac protection?.
International urology and nephrology 2004;36(4):617-23.
2003: Wenger Nanette K
Coronary heart disease: the female heart is vulnerable.
Progress in cardiovascular diseases 2003;46(3):199-229.
2003: Wenger Nanette K
HT and CVD prevention. from myth to reality.
Fertility and sterility 2003;80 Suppl 4():10-4; quiz 54-5.
2003: Wenger Nanette K
Is what's good for the gander good for the goose?
The Journal of thoracic and cardiovascular surgery 2003;126(4):929-31.
2003: Weber Michael A; Wenger Nanette K; Scheidt Stephen
New frontiers in cardiovascular aging.
The American journal of geriatric cardiology 2003;12(5):281-2.
2003: Scheidt Stephen; Wenger Nanette K; Weber Michael A
Drug therapy in the elderly.
The American journal of geriatric cardiology 2003;12(4):223-4.
2003: Thompson Paul D; Buchner David; Pina Ileana L; Balady Gary J; Williams Mark A; Marcus Bess H; Berra Kathy; Blair Steven N; Costa Fernando; Franklin Barry; Fletcher Gerald F; Gordon Neil F; Pate Russell R; Rodriguez Beatriz L; Yancey Antronette K; Wenger Nanette K;
Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).
Circulation 2003;107(24):3109-16.
2003: Wenger Nanette Kass
Nanette Kass Wenger, MD: a conversation with the editor [interviewed by William Clifford Roberts]
The American journal of cardiology 2003;91(10):1203-24.
2003: Wenger Nanette K; Scheidt Stephen; Weber Michael A
Anticoagulation at elderly age: the challenge to do better.
The American journal of geriatric cardiology 2003;12(3):151-2.
2003: Paoletti Rodolfo; Wenger Nanette K
Review of the International Position Paper on Women's Health and Menopause: a comprehensive approach.
Circulation 2003;107(9):1336-9.
2003: Wenger Nanette K
[The current state of hormonal prevention of coronary heart disease in menopausal women]
Revista española de cardiología 2003;56(1):1-8.
2003: Wenger Nanette K; Weber Michael A; Scheidt Stephen
Data-driven clinical care.
The American journal of geriatric cardiology 2003;12(1):5-6.
2003: Wenger Nanette K
Menopausal hormone therapy and cardiovascular protection: state of the data 2003.
Journal of the American Medical Women's Association (1972) 2003;58(4):236-9.
2003: Hall W Dallas; Clark Luther T; Wenger Nanette K; Wright Jackson T; Kumanyika Shiriki K; Watson Karol; Horton Ella W; Flack John M; Ferdinand Keith C; Gavin James R; Reed James W; Saunders Elijah; O'Neal Welton
For the patient. What is the Metabolic Syndrome and why is it important?
Ethnicity & disease 2003;13(4):546.
2003: Hall W Dallas; Clark Luther T; Wenger Nanette K; Wright Jackson T; Kumanyika Shiriki K; Watson Karol; Horton Ella W; Flack John M; Ferdinand Keith C; Gavin James R; Reed James W; Saunders Elijah; O'Neal Welton;
The Metabolic Syndrome in African Americans: a review.
Ethnicity & disease 2003;13(4):414-28.
2003: Wenger Nanette K
Reflections of a "lady doctor".
Journal of the Medical Association of Georgia 2003;92(2):13-4.
2002: Wenger Nanette Kass; Barrett-Connor Elizabeth; Collins Peter; Grady Deborah; Kornitzer Marcel; Mosca Lori; Sashegyi Andreas; Baygani Simin K; Anderson Pamela W; Moscarelli Elena
Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial.
The American journal of cardiology 2002;90(11):1204-10.
2002: Scheidt Stephen; Wenger Nanette K; Weber Michael A
Atrial fibrillation: many therapeutic options, but great uncertainty about optimal treatment.
The American journal of geriatric cardiology 2002;11(6):350-1.
2002: Wenger Nanette K
Usefulness of lipid-lowering therapy in elderly patients.
The American journal of cardiology 2002;90(8):870-1.
2002: Weber Michael A; Wenger Nanette K; Scheidt Stephen
Management of heart failure in the elderly: still much to be learned.
The American journal of geriatric cardiology 2002;11(5):281-2.
2002: Wenger Nanette K
Coronary heart disease and women: magnitude of the problem.
Cardiology in review 2002;10(4):211-3.
2002: Wenger Nanette K; Scheidt Stephen; Weber Michael
Drug treatment of cardiovascular problems at elderly age.
The American journal of geriatric cardiology 2002;11(4):214, 232.
2002: Wenger N K
Cardiovascular effects of raloxifene: the potential for cardiovascular protection in women.
Diabetes, obesity & metabolism 2002;4(3):166-76.
2002: Hooper W Craig; Dowling Nicole F; Wenger Nanette K; Dilley Anne; Ellingsen Dorothy; Evatt Bruce L
Relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans.
American journal of hematology 2002;70(1):1-8.
2002: Altobelli A; Scheidt Stephen; Wenger Nanette K; Weber Michael
Surgical coronary revascularization in the elderly.
The American journal of geriatric cardiology 2002;11(3):157-9.
2002: Williams Mark A; Fleg Jerome L; Ades Philip A; Chaitman Bernard R; Miller Nancy Houston; Mohiuddin Syed M; Ockene Ira S; Taylor C Barr; Wenger Nanette K;
Secondary prevention of coronary heart disease in the elderly (with emphasis on patients > or =75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention.
Circulation 2002;105(14):1735-43.
2002: Wenger Nanette K
Women, heart failure, and heart failure therapies.
Circulation 2002;105(13):1526-8.
2002: Weber Michael; Wenger Nanette K; Scheidt Stephen
The changing pattern of coronary heart disease in the elderly.
The American journal of geriatric cardiology 2002;11(2):79-80.
2002: Furberg Curt D; Vittinghoff Eric; Davidson Michael; Herrington David M; Simon Joel A; Wenger Nanette K; Hulley Stephen
Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned.
Circulation 2002;105(8):917-22.
2002: Wenger Nanette K
Clinical characteristics of coronary heart disease in women: emphasis on gender differences.
Cardiovascular research 2002;53(3):558-67.
2002: McNagny Sally E; Wenger Nanette K
Postmenopausal hormone-replacement therapy.
The New England journal of medicine 2002;346(1):63-5.
2002: Wenger Nanette K; Scheidt Stephen; Weber Michael A
Hypertension at elderly age: what we know and what we must learn.
The American journal of geriatric cardiology 2002;11(1):8-8.
2001: Shlipak M G; Simon J A; Grady D; Lin F; Wenger N K; Furberg C D;
Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease.
Journal of the American College of Cardiology 2001;38(3):705-11.
2001: Mosca L; Barrett-Connor E; Wenger N K; Collins P; Grady D; Kornitzer M; Moscarelli E; Paul S; Wright T J; Helterbrand J D; Anderson P W
Design and methods of the Raloxifene Use for The Heart (RUTH) study.
The American journal of cardiology 2001;88(4):392-5.
2001: Dilley A; Hooper W C; El-Jamil M; Renshaw M; Wenger N K; Evatt B L
Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C-->T677) and cystathione beta-synthase (CBS G-->A919, CBS T-->c833) are not associated with myocardial infarction in African Americans.
Thrombosis research 2001;103(2):109-15.
2001: Castellano P Z; Wenger N K; Graves W L
Adherence to screening guidelines for breast and cervical cancer in postmenopausal women with coronary heart disease: an ancillary study of volunteers for hers.
Journal of women's health & gender-based medicine 2001;10(5):451-61.
2001: Wenger N K
A cardiologist's view of hormone replacement therapy and alternatives for cardioprotection.
Journal of women's health & gender-based medicine 2001;10(3):257-60.
2000: Austin H; Hooper W C; Lally C; Dilley A; Ellingsen D; Wideman C; Wenger N K; Rawlins P; Silva V; Evatt B
Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans.
Journal of clinical epidemiology 2000;53(10):997-1001.
2000: Hooper W C; Lally C; Austin H; Renshaw M; Dilley A; Wenger N K; Phillips D J; Whitsett C; Rawlins P; Evatt B L
The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism.
Thrombosis research 2000;99(3):223-30.
2000: Grady D; Wenger N K; Herrington D; Khan S; Furberg C; Hunninghake D; Vittinghoff E; Hulley S
Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.
Annals of internal medicine 2000;132(9):689-96.
2000: Wenger N K
Lipid management and control of other coronary risk factors in the postmenopausal woman.
Journal of women's health & gender-based medicine 2000;9(3):235-43.
2000: Smith S C; Amsterdam E; Balady G J; Bonow R O; Fletcher G F; Froelicher V; Heath G; Limacher M C; Maddahi J; Pryor D; Redberg R F; Roccella E; Ryan T; Smaha L; Wenger N K
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: tests for silent and inducible ischemia: Writing Group II.
Circulation 2000;101(1):E12-6.
1999: Hooper W C; Lally C; Austin H; Benson J; Dilley A; Wenger N K; Whitsett C; Rawlins P; Evatt B L
The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans.
Chest 1999;116(4):880-6.
1999: Wenger N K; Grady D
Postmenopausal hormone therapy, SERMs, and coronary heart disease in women.
Journal of endocrinological investigation 1999;22(8):616-24.
1999: Wenger N K
Should women have a different risk assessment from men for primary prevention of coronary heart disease?
Journal of women's health & gender-based medicine 1999;8(4):465-7.
1999: Wenger N K
Women, myocardial infarction, and coronary revascularization: concordant and discordant clinical trial and registry data.
Cardiology in review 1999;7(2):117-20.
1998: Dilley A; Austin H; Hooper W C; El-Jamil M; Whitsett C; Wenger N K; Benson J; Evatt B
Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects.
The Journal of laboratory and clinical medicine 1998;132(6):452-5.
1998: Barrett-Connor E; Wenger N K; Grady D; Mosca L; Collins P; Kornitzer M; Cox D A; Moscarelli E; Anderson P W
Coronary heart disease in women, randomized clinical trials, HERS and RUTH.
Maturitas 1998;31(1):1-7.
1998: Wenger N K
Lipid metabolism, physical activity, and postmenopausal hormone therapy.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;32(5 Suppl 3):S80-8.
1998: Barrett-Connor E; Wenger N K; Grady D; Mosca L; Collins P; Kornitzer M; Cox D A; Moscarelli E; Anderson P W
Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene.
Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research 1998;7(7):839-47.
1998: Herrington D M; Fong J; Sempos C T; Black D M; Schrott H G; Rautaharju P; Bachorik P S; Blumenthal R; Khan S; Wenger N K
Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III)
American heart journal 1998;136(1):115-24.
1998: Hooper W C; Dilley A; Austin H; Wenger N K; Benson J; Evatt B L; Silva V; Rawlins P
Absence of mutations at APC cleavage sites Arg306 in factor V and Arg336, Arg562 in factor VIII in African-Americans.
Thrombosis and haemostasis 1998;79(1):236.
1998: Dilley A; Austin H; Hooper W C; Lally C; Ribeiro M J; Wenger N K; Silva V; Rawlins P; Evatt B
Relation of three genetic traits to venous thrombosis in an African-American population.
American journal of epidemiology 1998;147(1):30-5.
1997: McNagny S E; Wenger N K; Frank E
Personal use of postmenopausal hormone replacement therapy by women physicians in the United States.
Annals of internal medicine 1997;127(12):1093-6.
1997: Wenger N K
Rehabilitation of the coronary artery disease patient: capturing patients.
The American journal of cardiology 1997;80(8B):66H-68H.
1997: Wenger N K
Coronary heart disease: a substantial threat to women.
Journal of the Medical Association of Georgia 1997;86(3):187-91.
1996: Hooper W C; Dilley A; Ribeiro M J; Benson J; Austin H; Silva V; Rawlins P; Wenger N K; Evatt B L
A racial difference in the prevalence of the Arg506-->Gln mutation.
Thrombosis research 1996;81(5):577-81.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Nanette Wenger

Research Profile (preview)

Concepts & Ideas

Disorders

Geographic Areas

Procedures

Physiology

Activities & Behaviors

Chemicals & Drugs

Living Beings

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Nanette Wenger (preview)

All Publications